RYLPF Stock: Koninklijke Philips N.V. Stock Price, Analysis & Insights
Get live RYLPF stock price $25.99, comprehensive Koninklijke Philips N.V. stock analysis, charts, news, and expert forecast. Real-time RYLPF stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Koninklijke Philips N.V. functions as a prominent health technology enterprise, serving markets globally with a significant presence in North America. Its operations are structured around three core segments: Diagnosis & Treatment Businesses, Connect...
Company Information
- CEO
- Roy W. O. Jakobs
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 67247
Contact Information
- Website
- https://www.philips.com
- Address
- Philips Center
- Country
- NL
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 22.6)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Koninklijke Philips N.V. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Koninklijke Philips N.V.
- ⚠Investors should consider how Koninklijke Philips N.V. fits within their overall portfolio allocation
Market Cap
25.24B
P/E Ratio (TTM)
22.60
Beta
0.93
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RYLPF with peer companies:
- Price
- $5.85
- Market cap
- 18.69B
- Price
- $0.00
- Market cap
- 1.58K
- Price
- $64.00
- Market cap
- 33.70B
- Price
- $31.71
- Market cap
- 33.44B
- Price
- $203.66
- Market cap
- 19.82B
- Price
- $82.18
- Market cap
- 35.56B
- Price
- $15.10
- Market cap
- 12.82B
- Price
- $288.22
- Market cap
- 19.90B
- Price
- $14.97
- Market cap
- 22.08B
- Price
- $14.24
- Market cap
- 21.01B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.